Below are the financial statements of Edgewise Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of USD | 2024 | 2023 |
|---|---|---|
| Operating expenses | — | — |
| Research and development | -0.13a | -0.09a |
| General and administrative | -0.03a | -0.02a |
| Total operating expenses | -0.16a | -0.11a |
| Loss from operations | -0.16a | -0.11a |
| Other income | — | — |
| Interest income | 0.03a | 0.01a |
| Total other income | 0.03a | 0.01a |
| Net loss | -0.13a | -0.1a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Edgewise Therapeutics’s data sources below and access millions more through our Disclosure Search.